NGS's Principal Activity is the direct sale of products to end customers.
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
1 Week | |
1 Month | |
2022 YTD | |
1 Year | |
vs Sector (1yr) | -60.20% |
vs ASX 200 (1yr) | -49.99% |
Date | Heading | Pages | File Size | Time |
---|---|---|---|---|
Nutritional Growth Solutions Ltd (NGS) is a global nutritional health company focused on the well-being of children. NGS develops, produces and sells clinically tested nutritional supplement formulae for children following 20 years of medical research into paediatric nutrition at Schneider Children's Medical Centre, Israel's paediatric hospital.
No incorporation details available.
Head Office | Tel Aviv Israel 6971068 |
Website | www.ngsolutions.co |
Registry | Automic Group |
Auditor | BDO Ziv Haft |
Date Listed | 30 Oct 2020 |
Date | Event |
---|---|
18/08/2022 | Report (Interim) |
24/02/2023 | Report (Prelim) |
30/03/2023 | Report (Annual) |
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
NGS directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
The current holdings of NGS directors.
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Hadassa Bymel Pharmacy & Nature Ltd | 16/03/2022 | 8,098,652 | 6.86 |
Mor Research Applications Ltd | 16/03/2022 | 12,604,790 | 10.68 |
12 month transaction history compiled from ASX announcements.
No buy transactions reported by Substantial Shareholders in the past 12 months.
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Year | Closing Price | Last Trade |
---|---|---|
2021 | $0.24 | 30 June |
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.